176 related articles for article (PubMed ID: 16870790)
41. Cephalochromin, a FabI-directed antibacterial of microbial origin.
Zheng CJ; Sohn MJ; Lee S; Hong YS; Kwak JH; Kim WG
Biochem Biophys Res Commun; 2007 Nov; 362(4):1107-12. PubMed ID: 17825252
[TBL] [Abstract][Full Text] [Related]
42. A triclosan-resistant bacterial enzyme.
Heath RJ; Rock CO
Nature; 2000 Jul; 406(6792):145-6. PubMed ID: 10910344
[No Abstract] [Full Text] [Related]
43. In vitro activity of API-1252, a novel FabI inhibitor, against clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis.
Karlowsky JA; Laing NM; Baudry T; Kaplan N; Vaughan D; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2007 Apr; 51(4):1580-1. PubMed ID: 17220418
[No Abstract] [Full Text] [Related]
44. Verrulactones A and B, new inhibitors of Staphylococcus aureus enoyl-ACP reductase produced by Penicillium verruculosum F375.
Kim N; Sohn MJ; Kim CJ; Kwon HJ; Kim WG
Bioorg Med Chem Lett; 2012 Apr; 22(7):2503-6. PubMed ID: 22377515
[TBL] [Abstract][Full Text] [Related]
45. Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
Tasdemir D; Topaloglu B; Perozzo R; Brun R; O'Neill R; Carballeira NM; Zhang X; Tonge PJ; Linden A; Rüedi P
Bioorg Med Chem; 2007 Nov; 15(21):6834-45. PubMed ID: 17765547
[TBL] [Abstract][Full Text] [Related]
46. Virtual screening of antibacterial compounds by similarity search of Enoyl-ACP reductase (FabI) inhibitors.
Asse Junior LR; Kronenberger T; Magalhães Serafim MS; Sousa YV; Franco ID; Valli M; Silva Bolzani VD; Monteiro GC; Bruno Prates JL; Kroon EG; Fernandes Mota BE; Santos Ferreira DD; de Oliveira RB; Maltarollo VG
Future Med Chem; 2020 Jan; 12(1):51-68. PubMed ID: 31729258
[No Abstract] [Full Text] [Related]
47. 2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI.
Ramnauth J; Surman MD; Sampson PB; Forrest B; Wilson J; Freeman E; Manning DD; Martin F; Toro A; Domagala M; Awrey DE; Bardouniotis E; Kaplan N; Berman J; Pauls HW
Bioorg Med Chem Lett; 2009 Sep; 19(18):5359-62. PubMed ID: 19682900
[TBL] [Abstract][Full Text] [Related]
48. Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase.
Ochsner UA; Young CL; Stone KC; Dean FB; Janjic N; Critchley IA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4253-62. PubMed ID: 16189106
[TBL] [Abstract][Full Text] [Related]
49. Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI).
Miller WH; Seefeld MA; Newlander KA; Uzinskas IN; Burgess WJ; Heerding DA; Yuan CC; Head MS; Payne DJ; Rittenhouse SF; Moore TD; Pearson SC; Berry V; DeWolf WE; Keller PM; Polizzi BJ; Qiu X; Janson CA; Huffman WF
J Med Chem; 2002 Jul; 45(15):3246-56. PubMed ID: 12109908
[TBL] [Abstract][Full Text] [Related]
50. The antibacterial efficacy of an aceraceous plant [Shantung maple (Acer truncatum Bunge)] may be related to inhibition of bacterial beta-oxoacyl-acyl carrier protein reductase (FabG).
Zhang F; Luo SY; Ye YB; Zhao WH; Sun XG; Wang ZQ; Li R; Sun YH; Tian WX; Zhang YX
Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):73-8. PubMed ID: 18208374
[TBL] [Abstract][Full Text] [Related]
51. Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI).
Mehboob S; Song J; Hevener KE; Su PC; Boci T; Brubaker L; Truong L; Mistry T; Deng J; Cook JL; Santarsiero BD; Ghosh AK; Johnson ME
Bioorg Med Chem Lett; 2015 Mar; 25(6):1292-6. PubMed ID: 25677657
[TBL] [Abstract][Full Text] [Related]
52. Development of screening assays and discovery of initial inhibitors of pneumococcal peptidoglycan deacetylase PgdA.
Bui NK; Turk S; Buckenmaier S; Stevenson-Jones F; Zeuch B; Gobec S; Vollmer W
Biochem Pharmacol; 2011 Jul; 82(1):43-52. PubMed ID: 21501597
[TBL] [Abstract][Full Text] [Related]
53. In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
Yum JH; Kim CK; Yong D; Lee K; Chong Y; Kim CM; Kim JM; Ro S; Cho JM
Antimicrob Agents Chemother; 2007 Jul; 51(7):2591-3. PubMed ID: 17420210
[TBL] [Abstract][Full Text] [Related]
54. Implementation of permeation rules leads to a FabI inhibitor with activity against Gram-negative pathogens.
Parker EN; Drown BS; Geddes EJ; Lee HY; Ismail N; Lau GW; Hergenrother PJ
Nat Microbiol; 2020 Jan; 5(1):67-75. PubMed ID: 31740764
[TBL] [Abstract][Full Text] [Related]
55. A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase.
Levy CW; Baldock C; Wallace AJ; Sedelnikova S; Viner RC; Clough JM; Stuitje AR; Slabas AR; Rice DW; Rafferty JB
J Mol Biol; 2001 May; 309(1):171-80. PubMed ID: 11491286
[TBL] [Abstract][Full Text] [Related]
56. Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase.
Tipparaju SK; Joyasawal S; Forrester S; Mulhearn DC; Pegan S; Johnson ME; Mesecar AD; Kozikowski AP
Bioorg Med Chem Lett; 2008 Jun; 18(12):3565-9. PubMed ID: 18499454
[TBL] [Abstract][Full Text] [Related]
57. [Study on antibacterial activity of pheromonicin-SP].
Qin Y; Zhang J; Dai P; Sun L; Qiu XQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):109-12. PubMed ID: 17294741
[TBL] [Abstract][Full Text] [Related]
58. Benzothiophene carboxamide derivatives as inhibitors of Plasmodium falciparum enoyl-ACP reductase.
Banerjee T; Sharma SK; Kapoor N; Dwivedi V; Surolia N; Surolia A
IUBMB Life; 2011 Dec; 63(12):1101-10. PubMed ID: 22006792
[TBL] [Abstract][Full Text] [Related]
59. Identification of novel potential antibiotics for tuberculosis by in silico structure-based drug screening.
Izumizono Y; Arevalo S; Koseki Y; Kuroki M; Aoki S
Eur J Med Chem; 2011 May; 46(5):1849-56. PubMed ID: 21397998
[TBL] [Abstract][Full Text] [Related]
60. Identification of inhibitors of bacterial enoyl-acyl carrier protein reductase.
Moir DT
Curr Drug Targets Infect Disord; 2005 Sep; 5(3):297-305. PubMed ID: 16181147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
